{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:09:30Z","timestamp":1761707370538},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1067\/mem.2000.109511","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:20:53Z","timestamp":1027570853000},"page":"366-375","source":"Crossref","is-referenced-by-count":13,"title":["Nonoccupational HIV postexposure prophylaxis: A new role for the emergency department"],"prefix":"10.1067","volume":"36","author":[{"given":"Roland","family":"Clayton Merchant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mem.2000.109511_bib1","series-title":"Report on the Global HIV\/AIDS Epidemic\u2014December 1999","author":"Joint United Nations Programme on HIV\/AIDS and The World Health Organization","year":"1999"},{"key":"10.1067\/mem.2000.109511_bib2","author":"Centers for Disease Control and Prevention"},{"key":"10.1067\/mem.2000.109511_bib3","first-page":"1","volume":"11","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"HIV\/AIDS Surveillance Report"},{"key":"10.1067\/mem.2000.109511_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/00002030-199908200-00013","article-title":"Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status","volume":"13","author":"Ekstrand","year":"1999","journal-title":"AIDS"},{"key":"10.1067\/mem.2000.109511_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1467-842X.1998.tb01499.x","article-title":"Increase in unprotected anal intercourse with casual partners among Sydney gay men in 1996-98","volume":"22","author":"Van de Ven","year":"1998","journal-title":"Aust N Z J Public Health"},{"key":"10.1067\/mem.2000.109511_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0749-3797(98)00037-3","article-title":"Post-exposure prophylaxis for HIV infection in gay and bisexual men: implications for the future of HIV prevention","volume":"15","author":"Kalichman","year":"1998","journal-title":"Am J Prev Med"},{"key":"10.1067\/mem.2000.109511_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/0956462981920874","article-title":"Sexual exposure to HIV infection: is there a role for emergency prophylaxis?","volume":"9","author":"Desmond","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1067\/mem.2000.109511_bib8","article-title":"Should preventive HIV therapy be expanded? Officials ponder using drugs after accidental sexual exposure to AIDS virus","volume":"Z13","author":"Okie","year":"1997","journal-title":"The Washington Post"},{"key":"10.1067\/mem.2000.109511_bib9","article-title":"Morning-after HIV experiment starts in S.F.\/ Project to offer drugs, counseling","volume":"A2","author":"Perlman","year":"1997","journal-title":"San Francisco Chronicle"},{"key":"10.1067\/mem.2000.109511_bib10","article-title":"Morning after: HIV experts worry it will erase preventive gains","volume":"D1","author":"Painter","year":"1997","journal-title":"USA Today"},{"key":"10.1067\/mem.2000.109511_bib11","article-title":"Emergency treatment to stop AIDS virus","volume":"F7","author":"France","year":"1999","journal-title":"The New York Times"},{"issue":"RR-17","key":"10.1067\/mem.2000.109511_bib12","first-page":"1","article-title":"Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(88)91282-2","article-title":"Post-exposure prophylaxis against HIV infection in health care workers","volume":"1","author":"Meylan","year":"1988","journal-title":"Lancet"},{"issue":"RR-1","key":"10.1067\/mem.2000.109511_bib14","first-page":"1","article-title":"Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use","volume":"39","author":"Centers for Disease Control and Prevention","year":"1990","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib15","first-page":"929","article-title":"Case-control study of HIV seroconversaion in HCWs after percutaneous exposure to HIV infected blood\u2014France, United Kingdom, and United States, January 1988-August 1994","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2000.109511_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(97)00052-1","article-title":"Human immunodeficiency virus postexposure management of healthcare workers: report of a workshop","volume":"102","author":"Bell","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib18","first-page":"468","article-title":"Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-7","key":"10.1067\/mem.2000.109511_bib19","first-page":"1","article-title":"Public Health Service guidelines for the management of health care workers: exposures to HIV and recommendations for postexposure prophylaxis","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/bmj.299.6701.718","article-title":"Rape and subsequent seroconversion to HIV","volume":"299","author":"Murphy","year":"1989","journal-title":"BMJ"},{"key":"10.1067\/mem.2000.109511_bib21","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1001\/jama.261.23.3407b","article-title":"Anti-HIV substances for rape victims","volume":"261","author":"Foster","year":"1989","journal-title":"JAMA"},{"key":"10.1067\/mem.2000.109511_bib22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/bmj.299.6710.1282","article-title":"Rape and subsequent seroconversion to HIV","volume":"299","author":"Foster","year":"1989","journal-title":"BMJ"},{"key":"10.1067\/mem.2000.109511_bib23","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jama.1994.03510420068036","article-title":"HIV testing, counseling, and prophylaxis after sexual assault","volume":"271","author":"Goslin","year":"1994","journal-title":"JAMA"},{"issue":"RR-1","key":"10.1067\/mem.2000.109511_bib24","first-page":"1","article-title":"Guidelines for treatment of sexually transmitted diseases","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-9343(99)00018-2","article-title":"Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault","volume":"106","author":"Bamberger","year":"1999","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib26","series-title":"HIV Prophylaxis Following Sexual Assault: Guidelines for Adults and Adolescents","author":"AIDS Institute","year":"1998"},{"key":"10.1067\/mem.2000.109511_bib27","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199704103361512","article-title":"Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use","volume":"336","author":"Katz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2000.109511_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-128-4-199802150-00012","article-title":"The care of persons with recent sexual exposure to HIV","volume":"128","author":"Katz","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1067\/mem.2000.109511_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9343(97)00059-4","article-title":"Animal studies of prophylaxis","volume":"102","author":"Black","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/168.4.825","article-title":"Effects of initiation of 3'-azido,3'-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus","volume":"168","author":"Martin","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1067\/mem.2000.109511_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1749-6632.1990.tb17849.x","article-title":"Nonhuman primate models for evaluation of AIDS therapy","volume":"616","author":"McClure","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1067\/mem.2000.109511_bib32","first-page":"1086","article-title":"Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus","volume":"6","author":"Tsai","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mem.2000.109511_bib33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.270.5239.1197","article-title":"Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine","volume":"270","author":"Tsai","year":"1995","journal-title":"Science"},{"key":"10.1067\/mem.2000.109511_bib34","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus (SIV) depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"10.1067\/mem.2000.109511_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002030-199702000-00004","article-title":"Prevention of simian immunodeficiency virus, (SIV) or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005","volume":"11","author":"Bottiger","year":"1997","journal-title":"AIDS"},{"key":"10.1067\/mem.2000.109511_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1084\/jem.183.1.215","article-title":"Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques","volume":"183","author":"Spira","year":"1996","journal-title":"J Exp Med"},{"key":"10.1067\/mem.2000.109511_bib37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1126\/science.286.5443.1353","article-title":"Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells","volume":"286","author":"Zhang","year":"1999","journal-title":"Science"},{"key":"10.1067\/mem.2000.109511_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/sti.74.2.146","article-title":"Should preventive antiretroviral treatment be offered following sexual exposure to HIV?","volume":"74","author":"Evans","year":"1998","journal-title":"Not yet! Sex Transm Infect"},{"key":"10.1067\/mem.2000.109511_bib39","first-page":"167","article-title":"A double-blind, placebo-controlled study of the safety and efficacy of Retrovir (zidovudine) as a chemoprophylactic agent in health care workers exposed to HIV [abstract]","author":"Lafon","year":"1990"},{"key":"10.1067\/mem.2000.109511_bib40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2000.109511_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9343(97)00060-0","article-title":"Efficacy of zidovudine in preventing HIV transmission from mother to infant","volume":"102","author":"Balsley","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib42","first-page":"151","article-title":"Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission\u2014Thailand, 1996-1998","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(98)10411-7","article-title":"Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial","volume":"353","author":"Shaffer","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mem.2000.109511_bib44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","article-title":"Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus","volume":"339","author":"Wade","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2000.109511_bib45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mem.2000.109511_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0002-9343(97)00055-7","article-title":"The role of skin dendritic cells in the initiation of human immunodeficiency virus infection","volume":"102","author":"Blauvelt","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib47","article-title":"Post-exposure prophylaxis after sexual or drug use exposure to HIV: Final results from the San Francisco post-exposure prevention (PEP) project","author":"Martin","year":"1999"},{"key":"10.1067\/mem.2000.109511_bib48","article-title":"Evaluating seroconversion in the San Francisco post-exposure prevention project (PEP) [abstract]","author":"Roland","year":"1999"},{"key":"10.1067\/mem.2000.109511_bib49","series-title":"HIV Prevention Conference, Atlanta, GA","article-title":"Non-occupational post-exposure prophylaxis at a Boston community health center","author":"Kwong","year":"1999"},{"key":"10.1067\/mem.2000.109511_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9343(97)89442-9","article-title":"Candidate antiretroviral agents for use in postexposure prophylaxis","volume":"102","author":"Saag","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9343(97)00056-9","article-title":"Immune response to human immunodeficiency virus (HIV) in health care workers occupationally exposed to HIV-contaminated blood","volume":"102","author":"Pinto","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib52","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.280.20.1769","article-title":"Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical and policy considerations","volume":"280","author":"Lurie","year":"1998","journal-title":"JAMA"},{"key":"10.1067\/mem.2000.109511_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00042560-199604010-00010","article-title":"Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts","volume":"11","author":"Downs","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1067\/mem.2000.109511_bib54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(94)90990-3","article-title":"Probability of female-to-male transmission of HIV-1 in Thailand","volume":"343","author":"Mastro","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/mem.2000.109511_bib55","series-title":"11th International Conference on AIDS, Vancouver, British Columbia","first-page":"42","article-title":"HIV infectivity by contraceptive method from a partner study in northern Thailand","author":"Nagachinta","year":"1996"},{"key":"10.1067\/mem.2000.109511_bib56","first-page":"631","article-title":"Model-based optimization of infectivity parameters: a study of the early epidemic in San Francisco","volume":"3","author":"Ahlgren","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mem.2000.109511_bib57","first-page":"55","article-title":"Modeling HIV infectivity: must sex acts be counted?","volume":"3","author":"Kaplan","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mem.2000.109511_bib58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-113-10-740","article-title":"Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation","volume":"113","author":"Henderson","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1067\/mem.2000.109511_bib59","first-page":"1116","article-title":"A model-based estimate of HIV infectivity via needle sharing","volume":"5","author":"Kaplan","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mem.2000.109511_bib60","first-page":"285","article-title":"Zidovudine for the prevention of HIV transmission from mother to infant","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00042560-199601010-00012","article-title":"Mode of delivery and gestational age influence perinatal HIV-1 transmission","volume":"11","author":"Tovo","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1067\/mem.2000.109511_bib62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7326\/0003-4819-113-10-733","article-title":"Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations","volume":"113","author":"Donegan","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1067\/mem.2000.109511_bib63","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJM199704103361507","article-title":"Sexual transmission of HIV","volume":"336","author":"Royce","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2000.109511_bib64","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0895-4356(89)90098-X","article-title":"Infectiousness of HIV between male homosexual partners","volume":"42","author":"DeGruttola","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"10.1067\/mem.2000.109511_bib65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-125-6-199609150-00011","article-title":"Prophylaxis for occupational exposure to HIV","volume":"125","author":"Gerberding","year":"1996","journal-title":"Ann Intern Med"},{"issue":"Suppl 5B","key":"10.1067\/mem.2000.109511_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0002-9343(97)00068-5","article-title":"Combination chemotherapy for human immunodeficiency virus-1","volume":"102","author":"Manion","year":"1997","journal-title":"Am J Med"},{"key":"10.1067\/mem.2000.109511_bib67","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM199310073291502","article-title":"A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase","volume":"329","author":"Saag","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1067\/mem.2000.109511_bib68","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/infdis\/171.3.537","article-title":"High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection","volume":"171","author":"Havlir","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1067\/mem.2000.109511_bib69","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/JVI.68.3.1660-1666.1994","article-title":"Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy","volume":"68","author":"Richman","year":"1994","journal-title":"J Virol"},{"key":"10.1067\/mem.2000.109511_bib70","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/infdis\/172.5.1379","article-title":"A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of >500\/mm3: AIDS Clinical Trials Group Protocol 208","volume":"172","author":"Havlir","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1067\/mem.2000.109511_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"10.1067\/mem.2000.109511_bib72","first-page":"5","year":"1999","journal-title":"ACEP News"},{"key":"10.1067\/mem.2000.109511_bib73","first-page":"686","article-title":"A review of protease inhibitors (PI) use in 89 pregnancies [abstract]","author":"Morris","year":"1999"},{"key":"10.1067\/mem.2000.109511_bib74","series-title":"The Antiretroviral Pregnancy Registry Interim Report: 1 January 1989-31 January 1999","author":"Antiretroviral Pregnancy Registry","year":"1999"},{"issue":"RR-2","key":"10.1067\/mem.2000.109511_bib75","first-page":"1","article-title":"US Public Health Service task force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mem.2000.109511_bib76","author":"Department of Health and Human Services"},{"issue":"RR-4","key":"10.1067\/mem.2000.109511_bib77","first-page":"1","article-title":"Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064400956002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064400956002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:55:40Z","timestamp":1620003340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064400956002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0196064400956002"],"URL":"https:\/\/doi.org\/10.1067\/mem.2000.109511","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}